Role Of Two Homoeopathic Medicines In High Blood Pressure - A Comparative Trial

Role Of Predefined Homoeopathic Medicines Adrenalinum & Amylenum Nitrosum In Cases Of Hypertension - A Randomised Comparative Trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050695

Enrollment

143

Registered

2023-03-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Adrenalinum & Amylenum nitrosum: Adrenalinum Amylenum nitrosum Intervention2: Adrenalinum & Amylenum Nitrosum: Adrenalinum 30 & Amylenum Nitrosum 30 repetition according to patients

Eligibility

Inclusion criteria

Inclusion criteria: Mild and moderate cases of Hypertension with blood pressure upto Grade 1 and Grade 2 Prediagnosed or freshly diagnosed cases of Hypertension taking allopathic treatment Patient fulfilling the symptomatology of either of two medicines predefined Patient ready to sign the consent form

Exclusion criteria

Exclusion criteria: Patient with any other severe systemic disorders, autoimmune diseases, HIV patients Pregnant and lactating women Patient with blood pressure Grade 3 Patient not willing to sign consent

Design outcomes

Primary

Measure	Time frame
Blood Pressure will be assessed from this study we expect that both Adrenalinum & Amylenum nitrosum will give beneficial result in cases of Hypertension and one of the drug intervention will have better effect than other one When at baseline and after the admininstration of medicineTimepoint: 6 months	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR SHARAD SAXENA

MANGILAL NIRBAN HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE BIKANER

saxena.sharad2@gmail.com9829157873

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026